US 8940300
Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 8940300 (Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods) held by ADHERON THERAPEUTICS, INC. expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADHERON THERAPEUTICS, INC.
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61K39/3955, A61K45/06